Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities. // Biophysical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all
Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities. Biophysical Reports. https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all
“Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities.” Biophysical Reports.
@article{article11158,
title = {Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities},
journal = {Biophysical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...